XML 51 R39.htm IDEA: XBRL DOCUMENT
v3.25.3

Equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Equity [Abstract] |
Schedule of Stockholders Equity | The following table shows the changes in stockholders' equity for the nine months ended September 30, 2025:
(in millions) | Common Stock |  | Capital in Excess of Par Value |  | Retained Earnings |  | Accumulated Other Comprehensive (Loss) Income |  | Treasury Stock |  | Non-Controlling Interest |  | Total
Balance at January 1, 2025 | $ | 3 |  |  | $ | 8,687 |  |  | $ | 3,140 |  |  | $ | (435) |  |  | $ | (753) |  |  | $ | 5 |  |  | $ | 10,647 |
Net income attributable to Xylem | — |  |  | — |  |  | 169 |  |  | — |  |  | — |  |  | — |  |  | 169 |
Other comprehensive income (loss), net | — |  |  | — |  |  | — |  |  | 98 |  |  | — |  |  | — |  |  | 98 |
Dividends declared ($0.40 per share) | — |  |  | — |  |  | (98) |  |  | — |  |  | — |  |  | — |  |  | (98) |
Net income attributable to non-controlling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  | 1 |
Stock incentive plan activity | — |  |  | 18 |  |  | — |  |  | — |  |  | (13) |  |  | — |  |  | 5 |
Balance at March 31, 2025 | $ | 3 |  |  | $ | 8,705 |  |  | $ | 3,211 |  |  | $ | (337) |  |  | $ | (766) |  |  | $ | 6 |  |  | $ | 10,822 |
Net income attributable to Xylem | — |  |  | — |  |  | 226 |  |  | — |  |  | — |  |  | — |  |  | 226 |
Other comprehensive income (loss), net | — |  |  | — |  |  | — |  |  | 115 |  |  | — |  |  | — |  |  | 115 |
Other activity | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  | 1 |
Dividends declared ($0.40 per share) | — |  |  | — |  |  | (98) |  |  | — |  |  | — |  |  | — |  |  | (98) |
Distribution to minority shareholders | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2) |  |  | (2) |
Net income attributable to non-controlling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2 |  |  | 2 |
Stock incentive plan activity | — |  |  | 15 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 15 |
Balance at June 30, 2025 | $ | 3 |  |  | $ | 8,720 |  |  | $ | 3,339 |  |  | $ | (222) |  |  | $ | (766) |  |  | $ | 7 |  |  | $ | 11,081 |
Net income attributable to Xylem | — |  |  | — |  |  | 227 |  |  | — |  |  | — |  |  | — |  |  | 227 |
Other comprehensive (loss) income, net | — |  |  | — |  |  | — |  |  | (11) |  |  | — |  |  | — |  |  | (11) |
Other activity | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4 |  |  | 4 |
Dividends declared ($0.40 per share) | — |  |  | — |  |  | (97) |  |  | — |  |  | — |  |  | — |  |  | (97) |
Net income attributable to non-controlling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  | 1 |
Stock incentive plan activity | — |  |  | 15 |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | 14 |
Balance at September 30, 2025 | $ | 3 |  |  | $ | 8,735 |  |  | $ | 3,469 |  |  | $ | (233) |  |  | $ | (767) |  |  | $ | 12 |  |  | $ | 11,219 |
The following table shows the changes in stockholders' equity for the nine months ended September 30, 2024:
| Common Stock |  | Capital in Excess of Par Value |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Treasury Stock |  | Non-Controlling Interest |  | Total
Balance at January 1, 2024 | $ | 3 |  |  | $ | 8,564 |  |  | $ | 2,601 |  |  | $ | (269) |  |  | $ | (733) |  |  | $ | 10 |  |  | $ | 10,176 |
Net income attributable to Xylem | — |  |  | — |  |  | 153 |  |  | — |  |  | — |  |  | — |  |  | 153 |
Other comprehensive (loss) income, net | — |  |  | — |  |  | — |  |  | (76) |  |  | — |  |  | — |  |  | (76) |
Other activity | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2) |  |  | (2) |
Dividends declared ($0.36 per share) | — |  |  | — |  |  | (87) |  |  | — |  |  | — |  |  | — |  |  | (87) |
Stock incentive plan activity | — |  |  | 54 |  |  | — |  |  | — |  |  | (15) |  |  | — |  |  | 39 |
Balance at March 31, 2024 | $ | 3 |  |  | $ | 8,618 |  |  | $ | 2,667 |  |  | $ | (345) |  |  | $ | (748) |  |  | $ | 8 |  |  | $ | 10,203 |
Net income attributable to Xylem | — |  |  | — |  |  | 194 |  |  | — |  |  | — |  |  | — |  |  | 194 |
Other comprehensive (loss) income, net | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Other activity | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | (1) |
Dividends declared ($0.36 per share) | — |  |  | — |  |  | (87) |  |  | — |  |  | — |  |  | — |  |  | (87) |
Stock incentive plan activity | — |  |  | 42 |  |  | — |  |  | — |  |  | (3) |  |  | — |  |  | 39 |
Balance at June 30, 2024 | $ | 3 |  |  | $ | 8,660 |  |  | $ | 2,774 |  |  | $ | (345) |  |  | $ | (751) |  |  | $ | 7 |  |  | $ | 10,348 |
Net income attributable to Xylem | — |  |  | — |  |  | 217 |  |  | — |  |  | — |  |  | — |  |  | 217 |
Other comprehensive income (loss), net | — |  |  | — |  |  | — |  |  | 113 |  |  | — |  |  | — |  |  | 113 |
Other activity | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  | 1 |
Dividends declared ($0.36 per share) | — |  |  | — |  |  | (89) |  |  | — |  |  | — |  |  | — |  |  | (89) |
Stock incentive plan activity | — |  |  | 15 |  |  | — |  |  | — |  |  | (2) |  |  | — |  |  | 13 |
Distribution to minority shareholders | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | (1) |
Acquisition activity | — |  |  | (2) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2) |
Balance at September 30, 2024 | $ | 3 |  |  | $ | 8,673 |  |  | $ | 2,902 |  |  | $ | (232) |  |  | $ | (753) |  |  | $ | 7 |  |  | $ | 10,600 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration